Geoffrey Shiu Fei Ling, CEO of On Demand Pharmaceuticals and a former DARPA program manager, testifies in favor of creating ARPA-H to speed health care innovation. • Source: screenshot
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
